Publications by authors named "Keith Friedenberg"

Claim this Profile
L
Long-term safety of tenapanor in patients with irritable bowel syndrome with constipation in the T3MPO-3 study.
Anthony J Lembo, Keith A Friedenberg, Ronald P Fogel, Susan Edelstein, Suling Zhao

Neurogastroenterol Motil· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the vibrating capsule on colonic circadian rhythm and bowel symptoms in chronic idiopathic constipation.
Satish S C Rao, Anthony Lembo, William D Chey, Keith Friedenberg, Eamonn M M Quigley

Neurogastroenterol Motil· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The validity of breath collection bags method in detecting using the novel : a multicenter clinical study in 257 subjects.
Vered Richter, Jeff O Gonzalez, Sabine Hazan, Gary Gottlieb, Keith Friedenberg

Ther Adv Gastrointest Endosc· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease.
Stefan Schreiber, Corey A Siegel, Keith A Friedenberg, Ziad H Younes, Ursula Seidler

J Crohns Colitis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.
William J Sandborn, Joshua Korzenik, Bret Lashner, Jonathan A Leighton, Uma Mahadevan, Keith A Friedenberg

Gastroenterology· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis